117 related articles for article (PubMed ID: 35380751)
41. Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR.
Sichanh C; Quet F; Chanthavilay P; Diendere J; Latthaphasavang V; Longuet C; Buisson Y
BMC Cancer; 2014 Mar; 14():161. PubMed ID: 24602191
[TBL] [Abstract][Full Text] [Related]
42. Communities' perceptions towards cervical cancer and its screening in Wolaita zone, southern Ethiopia: A qualitative study.
Demissie BW; Azeze GA; Asseffa NA; Lake EA; Besha BB; Gelaw KA; Mokonnon TM; Gebeyehu NA; Obsa MS
PLoS One; 2022; 17(1):e0262142. PubMed ID: 34995307
[TBL] [Abstract][Full Text] [Related]
43. Cervical cancer screening knowledge and barriers among women in Addis Ababa, Ethiopia.
Getachew S; Getachew E; Gizaw M; Ayele W; Addissie A; Kantelhardt EJ
PLoS One; 2019; 14(5):e0216522. PubMed ID: 31075122
[TBL] [Abstract][Full Text] [Related]
44. Experiences and unmet needs of women undergoing Pap smear cervical cancer screening: impact on uptake of cervical cancer screening in south eastern Nigeria.
Chigbu CO; Onyebuchi AK; Egbuji CC; Ezugwu EC
J Cancer Educ; 2015 Mar; 30(1):81-5. PubMed ID: 24980966
[TBL] [Abstract][Full Text] [Related]
45. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
Fentie AM; Tadesse TB; Gebretekle GB
BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
[TBL] [Abstract][Full Text] [Related]
46. Cervical cancer awareness and screening in Botswana.
Mingo AM; Panozzo CA; DiAngi YT; Smith JS; Steenhoff AP; Ramogola-Masire D; Brewer NT
Int J Gynecol Cancer; 2012 May; 22(4):638-44. PubMed ID: 22367370
[TBL] [Abstract][Full Text] [Related]
47. Awareness and uptake of cervical cancer screening in Owerri, South-Eastern Nigeria.
Ezem BU
Ann Afr Med; 2007 Sep; 6(3):94-8. PubMed ID: 18240495
[TBL] [Abstract][Full Text] [Related]
48. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
Ndejjo R; Mukama T; Kiguli J; Musoke D
BMJ Open; 2017 Jun; 7(6):e016282. PubMed ID: 28606908
[TBL] [Abstract][Full Text] [Related]
49. Knowledge, attitude, practice and barriers of cervical cancer screening among women living in mid-western rural, Nepal.
Thapa N; Maharjan M; Petrini MA; Shah R; Shah S; Maharjan N; Shrestha N; Cai H
J Gynecol Oncol; 2018 Jul; 29(4):e57. PubMed ID: 29770627
[TBL] [Abstract][Full Text] [Related]
50. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
[TBL] [Abstract][Full Text] [Related]
51. Women diagnosed with HIV and unknown HIV status perceived susceptibility to cervical cancer and perceived benefits of cervical cancer screening in Ghana: a cross-sectional study.
Enyan NIE; Akaba S; Amoo SA
BMC Womens Health; 2021 Oct; 21(1):367. PubMed ID: 34657607
[TBL] [Abstract][Full Text] [Related]
52. Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya.
Rosser JI; Njoroge B; Huchko MJ
J Cancer Educ; 2015 Sep; 30(3):567-72. PubMed ID: 25595965
[TBL] [Abstract][Full Text] [Related]
53. Awareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco.
Belglaiaa E; Souho T; Badaoui L; Segondy M; Prétet JL; Guenat D; Mougin C
BMJ Open; 2018 Aug; 8(8):e020343. PubMed ID: 30139893
[TBL] [Abstract][Full Text] [Related]
54. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
[TBL] [Abstract][Full Text] [Related]
55. Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique.
Brandão M; Tulsidás S; Damasceno A; Silva-Matos C; Carrilho C; Lunet N
Eur J Cancer Prev; 2019 Jul; 28(4):338-343. PubMed ID: 30020115
[TBL] [Abstract][Full Text] [Related]
56. Barriers and facilitators to cervical cancer screening uptake among women in Nepal - a qualitative study.
Greibe Andersen J; Shrestha AD; Gyawali B; Neupane D; Kallestrup P
Women Health; 2020 Oct; 60(9):963-974. PubMed ID: 32643576
[TBL] [Abstract][Full Text] [Related]
57. Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.
Stuart A; Obiri-Yeboah D; Adu-Sarkodie Y; Hayfron-Benjamin A; Akorsu AD; Mayaud P
BMC Womens Health; 2019 Oct; 19(1):123. PubMed ID: 31647013
[TBL] [Abstract][Full Text] [Related]
58. Cervical Cancer Screening Positivity Among Women Living With HIV in CDC-PEPFAR Programs 2018-2022.
McCormick LJ; Gutreuter S; Adeoye O; Alger SX; Amado C; Bay Z; Chirwa CM; Chituwo O; Correia D; Deus M; Dirlikov E; Efuntoye T; Gunde L; Kabaghe A; Kalamya JN; Lorenzoni C; Magesa D; Mate C; Mulokoshi T; Ninsiima JC; Nyangasi M; Nyika P; Pasipamire M; Ssali M; Tefera F; Torre LA; Urso M; Wandira R; Zemburuka B; Montandon M
J Acquir Immune Defic Syndr; 2023 Dec; 94(4):301-307. PubMed ID: 37643419
[TBL] [Abstract][Full Text] [Related]
59. Acceptability of Self-Sampling for Cervical Cancer Screening Among Women Living With HIV and HIV-Negative Women in Limbé, Cameroon.
Pierz AJ; Ajeh R; Fuhngwa N; Nasah J; Dzudie A; Nkeng R; Anastos KM; Castle PE; Adedimeji A
Front Reprod Health; 2020; 2():561202. PubMed ID: 36304705
[No Abstract] [Full Text] [Related]
60. Barriers to uptake of cervical cancer screening among women in Nigeria: a systematic review.
Mafiana JJ; Dhital S; Halabia M; Wang X
Afr Health Sci; 2022 Jun; 22(2):295-309. PubMed ID: 36407354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
